UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Mosaic-Like Structure of Penicillin-Binding Protein 2 Gene (penA) in Clinical Isolates of Neisseria gonorrhoeae with Reduced Susceptibility to Cefixime

Antimicrobial Agents and Chemotherapy, 2002-12, Vol.46 (12), p.3744-3749

2002

Volltextzugriff (PDF)

In Vitro and In Vivo Antimicrobial Activities of T-3811ME, a Novel Des-F(6)-Quinolone

Antimicrobial Agents and Chemotherapy, 1999-05, Vol.43 (5), p.1077-1084

1999

Volltextzugriff (PDF)

Inhibitory Activities of Quinolones against DNA Gyrase of Chlamydia pneumoniae

Antimicrobial Agents and Chemotherapy, 2003-07, Vol.47 (7), p.2327-2329

2003

Volltextzugriff (PDF)

Pharmacodynamic evaluation of tosufloxacin against Streptococcus pneumoniae in an in vitro model simulating serum concentration

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2006-02, Vol.12 (1), p.1-8

2006

Volltextzugriff (PDF)

Influence of various antimicrobial agents on the intestinal flora in an intestinal MRSA-carrying rat model

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2004-12, Vol.10 (6), p.338-342

2004

Volltextzugriff (PDF)

In Vitro and In Vivo Efficacies of T-3811ME (BMS-284756) against Mycoplasma pneumoniae

Antimicrobial Agents and Chemotherapy, 2001-01, Vol.45 (1), p.312-315

2001

Volltextzugriff (PDF)

Inhibitory activity of garenoxacin against DNA gyrase of Mycoplasma pneumoniae

Journal of antimicrobial chemotherapy, 2012-08, Vol.67 (8), p.1850-1852

2012

Volltextzugriff (PDF)

In vitro pharmacodynamic evaluation of garenoxacin against quinolone-resistant Streptococcus pneumoniae

International journal of antimicrobial agents, 2012-02, Vol.39 (2), p.163-167

2012

Volltextzugriff (PDF)

Influence of inoculum size of Staphylococcus aureus and Pseudomonas aeruginosa on in vitro activities and in vivo efficacy of fluoroquinolones and carbapenems

Journal of antimicrobial chemotherapy, 2005-07, Vol.56 (1), p.91-96

2005

Volltextzugriff (PDF)

Therapeutic effects of garenoxacin in murine experimental secondary pneumonia by Streptococcus pneumoniae after influenza virus infection

Diagnostic microbiology and infectious disease, 2014-02, Vol.78 (2), p.168-171

2014

Volltextzugriff (PDF)

Evaluation of T-3811ME (BMS-284756), a New Des-F(6)-Quinolone, for Treatment of Meningitis Caused by Penicillin-Resistant Streptococcus pneumoniae in Rabbits

Antimicrobial Agents and Chemotherapy, 2002-06, Vol.46 (6), p.1760-1765

2002

Volltextzugriff (PDF)

Activity of Garenoxacin against Macrolide-Susceptible and -Resistant Mycoplasma pneumoniae

Antimicrobial agents and chemotherapy, 2007-06, Vol.51 (6), p.2278-2279

2007

Volltextzugriff (PDF)

In vitro and in vivo antibacterial activities of garenoxacin against group G Streptococcus dysgalactiae subsp. equisimilis

International journal of antimicrobial agents, 2011-09, Vol.38 (3), p.226-230

2011

Volltextzugriff (PDF)

Analysis of the NH2-Terminal 83rd Amino Acid of Escherichia coli GyrA in Quinolone-Resistance

MICROBIOLOGY and IMMUNOLOGY, 1995, Vol.39(4), pp.243-247

1995

Volltextzugriff (PDF)

Analysis of the NH2-Terminal 87th Amino Acid of Escherichia coli GyrA in Quinolone-Resistance

MICROBIOLOGY and IMMUNOLOGY, 1995, Vol.39(7), pp.517-520

1995

Volltextzugriff (PDF)

Quinolone susceptibility of norA-disrupted Staphylococcus aureus

Antimicrobial Agents and Chemotherapy, 1997-10, Vol.41 (10), p.2308-2309

1997

Volltextzugriff (PDF)

Mutations in the gyrA and grlA genes of quinolone-resistant clinical isolates of methicillin-resistant Staphylococcus aureus

Journal of antimicrobial chemotherapy, 1996-09, Vol.38 (3), p.543-546

1996

Volltextzugriff (PDF)

Antibacterial activities of tosufloxacin against anaerobic bacteria and the electron micrograph of its bactericidal effects

Chemotherapy (Basel), 1997-05, Vol.43 (3), p.153-158

1997

Volltextzugriff (PDF)

ENHANCEMENT OF 5-FLUOROURACIL UPTAKE INTO THE BACTERIAL CELL BY PIPERACILLIN

The Journal of Antibiotics, 1986, Vol.39(8), pp.1167-1171

1986

Volltextzugriff (PDF)

Antibacterial activity of quinolones against coagulase-negative staphylococci and the quinolone resistance-determining region of the gyrA genes from six species

Journal of antimicrobial chemotherapy, 1997-09, Vol.40 (3), p.383-386

1997

Volltextzugriff (PDF)

Vestaines, novel vasoactive compounds, isolated from Streptomyces sp. SANK 63697

Journal of antibiotics, 2017-02, Vol.70 (2), p.179-186

2017

Volltextzugriff (PDF)

F-36316 A and B, novel vasoactive compounds, isolated from Incrucipulum sp. SANK 10414

Journal of antibiotics, 2017-10, Vol.70 (10), p.981-986

2017

Volltextzugriff (PDF)

In Vitro Human Onychopharmacokinetic and Pharmacodynamic Analyses of ME1111, a New Topical Agent for Onychomycosis

Antimicrobial agents and chemotherapy, 2018-01, Vol.62 (1)

2018

Volltextzugriff (PDF)

Relationship between Preexisting Anti-Varicella-Zoster Virus (VZV) Antibody and Clinical VZV Reactivation in Hematopoietic Stem Cell Transplantation Recipients

Journal of Clinical Microbiology, 2006-12, Vol.44 (12), p.4441-4443

2006

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Aktive Filter

ThemaMicrobiology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(24)

Sprache

Englisch
(24)
Japanisch
(5)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Mosaic-Like Structure of Penicillin-Binding Protein 2 Gene (penA) in Clinical Isolates of Neisseria gonorrhoeae with Reduced Susceptibility to Cefixime

In Vitro and In Vivo Antimicrobial Activities of T-3811ME, a Novel Des-F(6)-Quinolone

Inhibitory Activities of Quinolones against DNA Gyrase of Chlamydia pneumoniae

Pharmacodynamic evaluation of tosufloxacin against Streptococcus pneumoniae in an in vitro model simulating serum concentration

Influence of various antimicrobial agents on the intestinal flora in an intestinal MRSA-carrying rat model

In Vitro and In Vivo Efficacies of T-3811ME (BMS-284756) against Mycoplasma pneumoniae

Inhibitory activity of garenoxacin against DNA gyrase of Mycoplasma pneumoniae

In vitro pharmacodynamic evaluation of garenoxacin against quinolone-resistant Streptococcus pneumoniae

Influence of inoculum size of Staphylococcus aureus and Pseudomonas aeruginosa on in vitro activities and in vivo efficacy of fluoroquinolones and carbapenems

Therapeutic effects of garenoxacin in murine experimental secondary pneumonia by Streptococcus pneumoniae after influenza virus infection

Evaluation of T-3811ME (BMS-284756), a New Des-F(6)-Quinolone, for Treatment of Meningitis Caused by Penicillin-Resistant Streptococcus pneumoniae in Rabbits

Activity of Garenoxacin against Macrolide-Susceptible and -Resistant Mycoplasma pneumoniae

In vitro and in vivo antibacterial activities of garenoxacin against group G Streptococcus dysgalactiae subsp. equisimilis

Analysis of the NH2-Terminal 83rd Amino Acid of Escherichia coli GyrA in Quinolone-Resistance

Analysis of the NH2-Terminal 87th Amino Acid of Escherichia coli GyrA in Quinolone-Resistance

Quinolone susceptibility of norA-disrupted Staphylococcus aureus

Mutations in the gyrA and grlA genes of quinolone-resistant clinical isolates of methicillin-resistant Staphylococcus aureus

Antibacterial activities of tosufloxacin against anaerobic bacteria and the electron micrograph of its bactericidal effects

ENHANCEMENT OF 5-FLUOROURACIL UPTAKE INTO THE BACTERIAL CELL BY PIPERACILLIN

Antibacterial activity of quinolones against coagulase-negative staphylococci and the quinolone resistance-determining region of the gyrA genes from six species

Vestaines, novel vasoactive compounds, isolated from Streptomyces sp. SANK 63697

F-36316 A and B, novel vasoactive compounds, isolated from Incrucipulum sp. SANK 10414

In Vitro Human Onychopharmacokinetic and Pharmacodynamic Analyses of ME1111, a New Topical Agent for Onychomycosis

Relationship between Preexisting Anti-Varicella-Zoster Virus (VZV) Antibody and Clinical VZV Reactivation in Hematopoietic Stem Cell Transplantation Recipients

Aktive Filter

Suchergebnisse filtern